Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study-Reference-Cited by-同舟云学术

Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study

Published:2002-11 Issue:17 Volume:38 Page:2279-2288
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Colozza M,Bisagni G,Mosconi A.M,Gori S,Boni C,Sabbatini R,Frassoldati A,Passalacqua R,Bian A.Rosa,Rodinò C,Rondini E,Algeri R,Di Sarra S,De Angelis V,Cocconi G,Tonato M

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. Early Breast Cancer Trialist Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992, 339, 1–15, 71–85.

2. Combination chemotherapy as an adjuvant treatment in operable breast cancer;Bonadonna;N Engl J Med.,1976

3. The effect on survival of initiating chemotherapy in advanced breast cancer;Ahmann;J Clin Oncol,1987

4. Primary chemotherapy for resectable breast cancer;Bonadonna,1993

5. Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial;Joensuu;J Clin Oncol,1998

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy;Breast Cancer Research and Treatment;2012-08-03

2. Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy;Journal of Clinical Oncology;2011-03-01

3. HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy;Journal of Clinical Oncology;2008-02-10

4. HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials;JNCI: Journal of the National Cancer Institute;2008-01-02

5. HER2/neu in systemic therapy for women with breast cancer: a systematic review;Breast Cancer Research and Treatment;2007-07-17